2019.02.18 FDA 510(k) The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]
2019.02.18 FDA 510(k) The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]
Pharmaceutical 2019.01.21 Annex 15: Qualification and Validation(邦訳) COPY TITLE&URL Annex15_Qualification_and_Validation_Jダウンロード https://youtu.be/Fbai3zbopvQ ]]>
Comment